Dr. Michael Nacol, MD

NPI: 1114915030
Total Payments
$13,410
2023 Payments
$985.36
Companies
51
Transactions
857
Medicare Patients
5,162
Medicare Billing
$627,213

Payment Breakdown by Category

Food & Beverage$13,284 (99.1%)
Education$125.07 (0.9%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $13,284 845 99.1%
Education $125.07 12 0.9%

Top Paying Companies

Company Total Records Latest Year
AstraZeneca Pharmaceuticals LP $1,638 83 $0 (2023)
GlaxoSmithKline, LLC. $1,465 97 $0 (2023)
Novo Nordisk Inc $1,434 99 $0 (2023)
Lilly USA, LLC $1,329 89 $0 (2023)
Boehringer Ingelheim Pharmaceuticals, Inc. $1,106 75 $0 (2023)
Amgen Inc. $949.01 66 $0 (2023)
ABBVIE INC. $512.86 29 $0 (2023)
Janssen Pharmaceuticals, Inc $448.09 32 $0 (2023)
Bayer Healthcare Pharmaceuticals Inc. $361.62 13 $0 (2023)
Merck Sharp & Dohme Corporation $341.01 49 $0 (2019)

Payment History by Year

Year Amount Transactions Top Company
2023 $985.36 46 Bayer Healthcare Pharmaceuticals Inc. ($258.85)
2022 $1,510 80 Novo Nordisk Inc ($271.03)
2021 $1,057 64 AbbVie Inc. ($171.56)
2020 $1,502 92 AstraZeneca Pharmaceuticals LP ($200.98)
2019 $2,546 191 Lilly USA, LLC ($377.51)
2018 $3,160 208 Lilly USA, LLC ($527.75)
2017 $2,650 176 AstraZeneca Pharmaceuticals LP ($407.04)

All Payment Transactions

857 individual payment records from CMS Open Payments — Page 1 of 35

Date Company Product Nature Form Amount Type
09/12/2023 Abbott Laboratories FREESTYLE LIBRE 3 (Device) Food and Beverage In-kind items and services $14.92 General
Category: Diabetes Care
08/31/2023 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $8.88 General
Category: Cardio-renal
08/23/2023 PFIZER INC. ELIQUIS (Drug), PAXLOVID, NURTEC ODT Food and Beverage In-kind items and services $27.46 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
08/22/2023 Abbott Laboratories FREESTYLE LIBRE 3 (Device) Food and Beverage In-kind items and services $23.19 General
Category: Diabetes Care
08/15/2023 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $22.23 General
Category: Cardio-renal
08/10/2023 Astellas Pharma US Inc Veozah (Drug) Food and Beverage In-kind items and services $25.02 General
Category: Biological
08/10/2023 ABBVIE INC. UBRELVY (Drug) Food and Beverage In-kind items and services $23.34 General
Category: NEUROSCIENCE
08/03/2023 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $14.11 General
Category: RESPIRATORY
07/26/2023 Novo Nordisk Inc Rybelsus (Drug), Ozempic Food and Beverage In-kind items and services $21.65 General
Category: Diabetes
07/24/2023 Lilly USA, LLC TRULICITY (Drug), MOUNJARO Food and Beverage In-kind items and services $17.95 General
Category: Diabetes
07/17/2023 Amgen Inc. Otezla (Drug), Repatha Food and Beverage In-kind items and services $26.55 General
Category: Inflammation
07/12/2023 Supernus Pharmaceuticals, Inc. TLANDO (Drug), XYOSTED Food and Beverage In-kind items and services $24.06 General
Category: TESTOSTERONE REPLACEMENT THERAPY
07/10/2023 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $138.81 General
Category: Cardio-renal
07/06/2023 Exact Sciences Corporation Cologuard Collection Kit (Device) Food and Beverage In-kind items and services $22.31 General
Category: Oncology
07/05/2023 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $20.14 General
Category: Cardio-renal
07/03/2023 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $20.60 General
Category: Cardiovascular and Metabolism
05/01/2023 Lilly USA, LLC MOUNJARO (Drug) Food and Beverage In-kind items and services $12.71 General
Category: Diabetes
04/27/2023 ABBVIE INC. UBRELVY (Drug), SYNTHROID Food and Beverage In-kind items and services $21.40 General
Category: NEUROSCIENCE
04/27/2023 Abbott Laboratories FREESTYLE LIBRE 3 (Device) Food and Beverage In-kind items and services $18.19 General
Category: Diabetes Care
04/26/2023 Antares Pharma, Inc. NOCDURNA (Drug), TLANDO, XYOSTED Food and Beverage In-kind items and services $12.73 General
Category: NOCTURIA DUE TO NOCTURNAL POLYURIA IN ADULTS
04/20/2023 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $20.68 General
Category: Cardiovascular and Metabolism
04/13/2023 Hikma Pharmaceuticals USA Ryaltris (Drug), Mitigare Food and Beverage In-kind items and services $15.34 General
Category: Pulmonary/Respiratory Diseases
04/05/2023 Amgen Inc. Otezla (Drug), Repatha Food and Beverage In-kind items and services $13.53 General
Category: Inflammation
04/04/2023 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $19.08 General
Category: Cardio-renal
03/29/2023 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $16.36 General
Category: RESPIRATORY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 8 717 1,091 $207,345 $75,025
2022 20 1,390 2,413 $453,480 $182,839
2021 18 1,480 2,648 $473,430 $195,467
2020 22 1,575 3,928 $492,134 $173,880
Total Patients
5,162
Total Services
10,080
Medicare Billing
$627,213
Procedure Codes
68

All Medicare Procedures & Services

68 procedure records from CMS Medicare Utilization — Page 1 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 342 592 $121,952 $44,895 36.8%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2023 134 134 $43,416 $16,895 38.9%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 145 201 $27,939 $10,447 37.4%
99442 Telephone medical discussion with physician, 11-20 minutes Office 2023 19 19 $2,888 $878.12 30.4%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 12 12 $3,840 $855.26 22.3%
96372 Injection of drug or substance under skin or into muscle Office 2023 33 80 $5,600 $628.19 11.2%
J1040 Injection, methylprednisolone acetate, 80 mg Office 2023 21 42 $1,050 $371.54 35.4%
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report Office 2023 11 11 $660.00 $56.00 8.5%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 497 1,215 $250,290 $105,472 42.1%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2022 174 174 $56,376 $22,399 39.7%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 237 371 $51,569 $21,438 41.6%
99442 Telephone medical discussion with physician, 11-20 minutes Office 2022 102 140 $21,280 $7,864 37.0%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 45 45 $14,400 $4,086 28.4%
99496 Transitional care management services for problem of high complexity Office 2022 18 18 $8,352 $3,786 45.3%
90670 Pneumococcal vaccine, 13-valent Office 2022 12 12 $4,656 $2,973 63.9%
99495 Transitional care management services for problem of moderate complexity Office 2022 14 14 $4,620 $2,266 49.1%
90694 Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage Office 2022 31 32 $5,856 $2,248 38.4%
G0438 Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit Office 2022 11 11 $5,346 $1,813 33.9%
90732 Pneumococcal vaccine, 23-valent Office 2022 13 13 $2,236 $1,704 76.2%
96372 Injection of drug or substance under skin or into muscle Office 2022 43 160 $11,200 $1,576 14.1%
G0008 Administration of influenza virus vaccine Office 2022 51 52 $3,640 $1,476 40.6%
G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and Office 2022 29 32 $5,120 $1,333 26.0%
G0179 Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a Office 2022 18 28 $3,416 $831.18 24.3%
G0009 Administration of pneumococcal vaccine Office 2022 27 27 $1,890 $770.90 40.8%
90686 Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage Office 2022 19 19 $1,121 $400.71 35.7%

About Dr. Michael Nacol, MD

Dr. Michael Nacol, MD is a Internal Medicine healthcare provider based in Georgetown, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/13/2005. The National Provider Identifier (NPI) number assigned to this provider is 1114915030.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Nacol, MD has received a total of $13,410 in payments from pharmaceutical and medical device companies, with $985.36 received in 2023. These payments were reported across 857 transactions from 51 companies. The most common payment nature is "Food and Beverage" ($13,284).

As a Medicare-enrolled provider, Nacol has provided services to 5,162 Medicare beneficiaries, totaling 10,080 services with total Medicare billing of $627,213. Data is available for 4 years (2020–2023), covering 68 distinct procedure/service records.

Practice Information

  • Specialty Internal Medicine
  • Location Georgetown, TX
  • Active Since 10/13/2005
  • Last Updated 01/08/2010
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1114915030

Products in Payments

  • JARDIANCE (Drug) $1,299
  • FARXIGA (Drug) $1,234
  • Ozempic (Drug) $459.80
  • TRELEGY ELLIPTA (Drug) $428.12
  • ANORO (Drug) $396.95
  • Kerendia (Drug) $361.62
  • Victoza (Drug) $351.42
  • SYMBICORT (Drug) $345.77
  • NUCALA (Biological) $318.50
  • TRULICITY (Drug) $307.54
  • JANUVIA (Drug) $297.79
  • XARELTO (Drug) $273.65
  • EMGALITY (Drug) $268.60
  • Tymlos (Biological) $256.39
  • Aimovig (Biological) $237.76
  • Rybelsus (Drug) $236.01
  • VRAYLAR (Drug) $231.36
  • NATPARA (Drug) $229.61
  • Prolia (Biological) $227.81
  • EVENITY (Biological) $226.40

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Georgetown